论文部分内容阅读
运用单向免疫扩散法测血SP_1、用反向被动血凝法测HPL、24小时尿E_3测定孕妇139例(其中正常妊娠90例,高危妊娠49例)。以单项、双项、三项测定指标均正常为对照组共80例(低Apgar评分发生率为13.7％,胎盘病检异常为8.80％,新生儿合并症为5.0％,无围产儿死亡)。而病例组单项、双项低值Apgar评分发生率为34.8％和32％与对照组相比(P<0.05),三项低值低Ap gar评分45.5％(P<0.01),胎盘病检异常的单、双、三项低值发生率与正常组比较均P<0.01;新生儿合并症双项(24％)、三项(36.4％)与对照组相比P<0.01,病例组围产儿死亡2例。
One-way immunodiffusion was used to measure blood SP_1, HPL was measured by reverse passive hemagglutination, and 139 pregnant women (including 90 normal pregnant women and 49 high-risk pregnant women) were measured by 24-hour urine E_3. A single, double, three indicators were normal for the control group, a total of 80 cases (low Apgar score was 13.7%, placental abnormalities was 8.80%, neonatal complications were 5.0%, no perinatal death). In the case group, the incidences of single-item and double-item low-grade Apgar scores were 34.8% and 32% respectively (P <0.05), three low-value Apgar scores were 45.5% (P <0.01) (P <0.01). The incidence of neonatal complications was significantly higher than that of the control group (P <0.01). The incidence of neonatal complications was significantly higher than that of the control group (24%) and three items 2 died.